MEDICINAL
CHEMISTRY-I – 3RD B-Pharm (75 Hours)
First Sessional
Sl.No. |
Chapter
No |
Topic |
Sub
Topic |
Hours |
01. 02 03 |
Chapter
No-01 Chapter No-02 Chapter No-03 |
Central
nervous system depressants Local anesthetic Analgesic agents |
A.
General anesthetics: 1.
Inhalation anesthetics: Halothane,
Methoxy flurane, Nitrous oxide. 2.
Ultra short acting barbiturates: Methohextial
sodium, Thiopental sodium. 3.
Dissociative anaesthtics: Ketamine
hydrochloride. B.
Anxiolytic, sedative and hypnotic agents: 1.
SAR of Benzodiazpine Chloriazepoxide,
Diazepam, Oxazepam, Chlorazepam,
Lorazepam, Flurazepam, Alprazolam. 2.
SAR of Barbiturates: a)
Barbital, methabarbital, Phenobarbital, b)
Amobarbital, Butabarbital, c)
Pentobarbital, Secobarbital 3.
Miscellaneous sedative hypnotics: a) Amides and Imides: Glutehmide,
Methprylon, Methaqualone. b)
Alcohols and their carbomate derivatives: Ethchlorvynol, Ethinamate, Meprobomate. c)
Aldehydes and their derivatives: Chloral hydrate,
paraldehyde. d)
Skeletal muscle relaxants: Chlorphensin, Methocarbamol, e)
Drugs used in spasticity: Baclofen, Buspirone. f) Anticonvulsants: 1. Mechanism of anticonvulsant
action. 2. Barbiturates
; Phenobarbitone. 3. Hydantoins : phenytoin sodium, Ethitoin, Mephenytoin. 4. Oxazolidine
diones :
Trimethadone, Paramethadone. 5. Succinimides : Phensuximides, Methsuximide, Ethosuximide, Trimethadone. 6. Urea and monoacylureas
: Phenacetamide, 7. Miscellaneous
: Primidone, Valproic
acid. 8. Benzodiazepines
: Clonazepam, Diazepam, Chlorazepam. Local
anaesthetics a) Histroical
development, mechanism of action of local anaesthetics. b) SAR of- Benzoic acid
derivatives, Lidocaine derivatives. c) 1. Benzoic acid derivatives, Hexylcaine, Cylomethycaine, Pierocaine. 2. Amino benzoic acid derivatives:
Benzocaine, Procaine, Procainanmide. 3. Lidocaine
derivatives (Anilides): Lidocaine,Prilocaine. 4. Miscellaneous: Dimethisoquin, Dibucaine. Carbamazepam. Analgesic
agents A) Structure and use of morphine,
codeine and diacetyl morphine. b) Narcotic Antagonists: Structure
and uses of Nalorphine, Levalorphan. c) Antitussive
agents: Structure and uses of Noscapine, Dextromethorphan. d) Peripheral and Nuclear
modification of Morphine. e) Anti-Inflammatory agents. 1. Salicylic acid derivatives:
Sodium Salicylate. 2. N-aryl anthranilic
derivatives: mefenimic acid, diclofenac
sod. 3. Aryl Acetic acid derivatives: Indomethacin,Ibuprofen, Piroxican. 4. aniline and p.aminophenol
derivatives: , acetaminophen phenacetin 5. pyrazololone
and pyrazolidinedione: Antipyrin, aminopyrin, oxypenbutazone, phenylbutazone |
(02Hours) (01Hours) (01Hours) (06 Hours) (01 hours) (03Hours) (03
hours) (04
hours) (04 hours) |
Second Sessional
Sl.No. |
Chapter
No |
Topic |
Sub
Topic |
Hours |
04 |
Chapter
No-04 |
Adrenergic
agents: |
a)
Adrenergic neurotransmitters: function structure and physicochemical Properties, biosynthesis
and metabolism of noradrenaline. b)
Adrenergic receptors: alpha and beta-adrenergic receptors,
their distribution in the human body. c)
Sympathomimetic agents: 1.
Direct acting agents; Definition and examples: Phenylethylamine,
Noradrenaline. 2.
Indirect acting agents: Definition and example: Isoproterneol, Trbutalin. 3.
Agents with mixed mechanism : examples: Clonidine. 4.
Alpha Adrenergic receptor agonists: Example: Ergotamine. 5.
Beta Adrenergic receptor agonists: Example Pseudoephidrine. 6.
Aliphatic amines: Triaminoheptane, Cyclopentamine, 7.
Imidazoline derivatives : Naphazoline,
Tetrahydrazoline, Oxymetazoline, Xylometaxazoline. D)
Adrenergic blocking agents 1.
Neuronal blocking agents: Alpha-Adrenergic blocking agents –ergot alkaloids 2.
Beta halo alkyl amines: Dibenzamine, Phenoxybenzamine. 3.Imidazolines: Talazoline,
Phentolamine, Prazocin. 4.
Beta Adrenergic blocking agents: Propanlol,
4-hydroxy propranolol practolol,
Metaprolol. |
(02 Hours) (05Hours) (03Hours) |
05 |
Chapter
No-05 |
Cholinergic
drugs and related agents |
Cholinergic drugs and
related agents 1.
Cholinergic neurotransmitter: function, structure, physiochemical properties,
biosynthesis and metabolism of Acetylcholine. Cholinergic receptors: muscarnic and nicotinic receptor, their distribution in
the human body. 2.
Indirectly acting Cholinergic agonists: a) Cholinestrase
inhibitors: Physostigmine, Neostigmine,
Pyridostigmine. b)
Irreversible inhibitors : Malathion,
Parathion. b)
Cholinergic
blocking agents: Parasympathetic Postganglionic blocking agents: Atropine, Hyoscyamine, Scoplamine, Homatropine, Methscopolamine. C)
Synthesis
Cholinergic blocking agents: Cidinium bromide, Dicyclomine, Propantheline, Benzotropine Chlorphenoxamine, d)
Ganglionic blocking agents: Trimethaphan camsylate, Mecamylamine. e)
Neuromuscular
blocking agents: d-Tubocurarine chloride, Metocurine iodide synthetic compounds with curare form
activity-Decamethonium bromide. |
(07hours) (08hours) |
Third Sessional
Sl.No |
Chapter
No |
Topic |
Sub
Topic |
Hours |
|
06 07 |
Chapter
No-06 Chapter
No-07 |
Basic
Principles Medicinal Chemistry Prostaglandins
and other Eicosaniods |
A) A brief introduction to
the subject, history and development of medicinal Chemistry, definition and
fundamental principal of drug therapy. B) Effects of the following
physicochemical properties of drug molecules on biological activity:
Solubility, partition coefficient, hydrogen bonding, protein binding, chelation, Geometrical and potical
isomers, redox potential, ionization and surface
activity. C) Principles of drug design
(theoretical aspects) General principles of drug action and drug receptor
interaction. D) Drug metabolism: General
pathways of drug metabolism, sites of drug biotransformations,
role of cytochrome P-450 and monoaminooxygenase
in oxidative biotransformations. Oxidative,
reductive, hydrolytic and conjugation reaction. Factors affecting drug
metabolism. E) Study of the development
of the following classes of drugs including structure activity realationship (SAR),mechanisms of action, synthesis of
compounds underlined and superscribed by “s”
chemical nomenclature, generic, names, brand names (a few important markted products and side effects. a)
History and discovery b)
Eicosaniods
biosynthesis c)
Drug action mediated by Eicosaniods. d)
Design of Eicosaniods drug. e)
Eicosaniods approved for human clinical use. f)
Prostaglandin F2 a, Prostaglandin E2,15-(s)-methyl-PG. F2 a Prostaglandin E1,
16-(R,S) methyl-16-hydroxy-methyl ster. |
(02Hours) (06Hours) (02Hours) (07Hours) (05Hours) |
|
08 |
Chapter
No-08 |
Histamines
and anti histaminic agents |
a)
Histamine, receptors and their distribution in the human body. b)
Antihistaminic agents: H1 antagonists. 1)
Amino alkyl eithers: Diphenhydramine
hydrochloride, Bromodiphenhydramine, Doxylamine. 2)
Ethylene diamines: Tripelennamine,
Pyrilamine. 3)
Peopylamine derivatives: Pheniramine,
Chlorpheniramine. 4)
Phenothiazine derivatives: Promethazine,
Trimeprazine. 5)
Piperazine derivatives: Cyclizine,
Meclizine. 6)
Miscellaneous compounds : Phenindamine,
Cyproheptidine.C H2-Antogonists: Mechanism of
H2-Antogonists Cemetidine, Rantidine. Gastric
proton pump inhibitor-an introduction Omeprazole. |
(03Hours) |
|